Tissue Plasminogen Activator (tPA) Antigen Build info
Synonyms |
|
||||||||||||
Short Name |
TISSUE PLASMINOGEN ACTIVATOR |
||||||||||||
Procedure Master Number |
LAB12260 |
||||||||||||
Procedure ID |
|||||||||||||
Clinical Info |
As the primary mediator of endogenous fibrinolysis, elevated tPA levels are strongly associated with an increased risk of arterial vascular disease and have been shown to indicate risk of future myocardial infarction. |
||||||||||||
Specimen Type |
Blood |
||||||||||||
Container |
Blue Top Tube |
||||||||||||
Collection Instructions |
Container/Tube: Blue-top (3.2% sodium citrate) tube |
||||||||||||
Transport Instructions |
Frozen |
||||||||||||
Specimen Stability |
|||||||||||||
Methodology |
Tissue plasminogen activator is bound to the wells of a microtiter plate by anti-tPA monoclonal antibodies. Unbound material is washed out of the wells. Bound tPA converts a chromogenic substrate to produce color. |
||||||||||||
Days Performed |
|||||||||||||
Performing Laboratory |
Labcorp-Esoterix |
||||||||||||
CPT |
85415 |
||||||||||||
PDM |
5600600 |
||||||||||||
Results |
|